表紙
市場調查報告書

牙科生物材料的全球市場:2020年∼2024年

Dental Biomaterials Market by Product and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 918556
出版日期 內容資訊 英文 150 Pages
訂單完成後即時交付
價格
牙科生物材料的全球市場:2020年∼2024年 Dental Biomaterials Market by Product and Geography - Forecast and Analysis 2020-2024
出版日期: 2019年11月21日內容資訊: 英文 150 Pages
簡介

全球牙科用生物材料市場上,牙科疾病的增加,新產品的銷售,M&A活動的增加等成為成長促進因素,在預測期間內預計將以約7%的年複合成長率擴大。可是,醫療治療相關的高成本,開發中國家的替代品存在和認識不足,及牙科骨移植嚴格的法規與併發症等要素,可能妨礙在預測期間內的牙科生物材料產業的成長。

本報告提供全球牙科生物材料市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2019年)
  • 市場規模及預測(2019年∼2024年)
  • 市場預測

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各產品

  • 市場區隔:各產品
  • 比較:產品市場規模及預測(2019年∼2024年)
  • 骨移植
  • 薄膜及組織再生產品
  • 市場機會:各產品

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 策略性聯盟的增加
  • 牙科用生物材料的技術的進步與創新

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Advanced Medical Solutions Group Plc
  • Biomatlante SA
  • DENTSPLY SIRONA Inc.
  • Envista Holdings Corp.
  • Geistlich Pharma AG
  • Henry Schein Inc.
  • Medtronic Plc
  • Straumann Holding AG
  • Tissue Regenix Group Plc
  • Zimmer Biomet Holdings Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR40190

About this market

Technavio's dental biomaterials market analysis considers sales from bone grafts and membranes and tissue regeneration products. Our study also finds the sales of dental biomaterials in Asia, Europe, North America, and ROW. In 2019, the bone grafts segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the launch of innovative grafts and technological advances will play a significant role in the bone grafts segment to maintain its market position. Also, our global dental biomaterials market report looks at factors such as the increasing prevalence of dental conditions, new product launches, and the growing number of M&A activities. However, high costs associated with medicinal procedures, presence of substitutes and lack of awareness in developing countries, and stringent regulations and complications with dental bone grafts may hamper the growth of the dental biomaterials industry over the forecast period.

Overview

Increasing prevalence of dental conditions

There is a growing prevalence of dental disorders such as tooth decay and periodontal diseases owing to changing food habits and lifestyles, consumption of tobacco, smoking, and poor oral health. The growth of the geriatric population has further increased the prevalence of periodontal diseases across the world. This has increased the demand for biomaterials for tissue engineering and several methods of regenerative periodontal therapies, such as the use of bone graft, barrier membrane, and combined procedures for the treatment of periodontal diseases. Thus, the increasing prevalence of dental conditions will lead to the expansion of the global dental biomaterials market at a CAGR of almost 7% during the forecast period.

Technological advances and innovations in dental biomaterials

Digital technology and diagnostic tools such as CAD/CAM, digitally assisted treatment planning for implant surgery/restorations, and caries diagnosis tools have shifted dentistry to a new level. The application of artificial intelligence (Al) is expected to have a significant impact on dental care, which will open a range of applications for dental biomaterials. New grafts and molecules with biomimetic and biological properties play a crucial role in the functional rehabilitation of bone defects. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global dental biomaterials market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of several major players, the global dental biomaterials market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading milk chocolate manufacturers, that include Advanced Medical Solutions Group Plc, Biomatlante SA, DENTSPLY SIRONA Inc., Envista Holdings Corp., Geistlich Pharma AG, Henry Schein Inc., Medtronic Plc, Straumann Holding AG, Tissue Regenix Group Plc, and Zimmer Biomet Holdings Inc.

Also, the dental biomaterials market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Value chain analysis
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Bone grafts - Market size and forecast 2019-2024
  • Membranes and tissue regeneration products -
  • Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Growing number of strategic alliances
  • Technological advances and innovations in dental biomaterials

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Advanced Medical Solutions Group Plc
  • Biomatlante SA
  • DENTSPLY SIRONA Inc.
  • Envista Holdings Corp.
  • Geistlich Pharma AG
  • Henry Schein Inc.
  • Medtronic Plc
  • Straumann Holding AG
  • Tissue Regenix Group Plc
  • Zimmer Biomet Holdings Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare supplies market
  • Exhibit 02: Segments of global healthcare supplies market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Product overview
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Product - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Bone grafts - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Bone grafts - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Membranes and tissue regeneration products - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Membranes and tissue regeneration products - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Population aged 65 years and above 2015 and 2018 (% of total population)
  • Exhibit 34: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 35: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Product launch details
  • Exhibit 40: M&A and their market impact analysis
  • Exhibit 41: Impact of drivers and challenges
  • Exhibit 42: Types of strategic alliances
  • Exhibit 43: Vendor landscape
  • Exhibit 44: Landscape disruption
  • Exhibit 45: Vendors covered
  • Exhibit 46: Vendor classification
  • Exhibit 47: Market positioning of vendors
  • Exhibit 48: Advanced Medical Solutions Group Plc - Vendor overview
  • Exhibit 49: Advanced Medical Solutions Group Plc - Business segments
  • Exhibit 50: Advanced Medical Solutions Group Plc - Geographic focus
  • Exhibit 51: Advanced Medical Solutions Group Plc - Segment focus
  • Exhibit 52: Advanced Medical Solutions Group Plc - Key offerings
  • Exhibit 53: Advanced Medical Solutions Group Plc - Key customers
  • Exhibit 54: Biomatlante SA - Vendor overview
  • Exhibit 55: Biomatlante SA - Product segments
  • Exhibit 56: Biomatlante SA - Organizational developments
  • Exhibit 57: Biomatlante SA - Key offerings
  • Exhibit 58: Biomatlante SA - Key customers
  • Exhibit 59: DENTSPLY SIRONA Inc. - Vendor overview
  • Exhibit 60: DENTSPLY SIRONA Inc. - Business segments
  • Exhibit 61: DENTSPLY SIRONA Inc. - Organizational developments
  • Exhibit 62: DENTSPLY SIRONA Inc. - Geographic focus
  • Exhibit 63: DENTSPLY SIRONA Inc. - Segment focus
  • Exhibit 64: DENTSPLY SIRONA Inc. - Key offerings
  • Exhibit 65: DENTSPLY SIRONA Inc. - Key customers
  • Exhibit 66: Envista Holdings Corp. - Vendor overview
  • Exhibit 67: Envista Holdings Corp. - Business segments
  • Exhibit 68: Envista Holdings Corp. - Key offerings
  • Exhibit 69: Envista Holdings Corp. - Key customers
  • Exhibit 70: Geistlich Pharma AG - Vendor overview
  • Exhibit 71: Geistlich Pharma AG - Product segments
  • Exhibit 72: Geistlich Pharma AG - Organizational developments
  • Exhibit 73: Geistlich Pharma AG - Key offerings
  • Exhibit 74: Geistlich Pharma AG - Key customers
  • Exhibit 75: Henry Schein Inc. - Vendor overview
  • Exhibit 76: Henry Schein Inc. - Product segments
  • Exhibit 77: Henry Schein Inc. - Organizational developments
  • Exhibit 78: Henry Schein Inc. - Geographic focus
  • Exhibit 79: Henry Schein Inc. - Segment focus
  • Exhibit 80: Henry Schein Inc. - Key offerings
  • Exhibit 81: Henry Schein Inc. - Key customers
  • Exhibit 82: Medtronic Plc - Vendor overview
  • Exhibit 83: Medtronic Plc - Business segments
  • Exhibit 84: Medtronic Plc - Organizational developments
  • Exhibit 85: Medtronic Plc - Geographic focus
  • Exhibit 86: Medtronic Plc - Segment focus
  • Exhibit 87: Medtronic Plc - Key offerings
  • Exhibit 88: Medtronic Plc - Key customers
  • Exhibit 89: Straumann Holding AG - Vendor overview
  • Exhibit 90: Straumann Holding AG - Product segments
  • Exhibit 91: Straumann Holding AG - Organizational developments
  • Exhibit 92: Straumann Holding AG - Geographic focus
  • Exhibit 93: Straumann Holding AG - Segment focus
  • Exhibit 94: Straumann Holding AG - Key offerings
  • Exhibit 95: Straumann Holding AG - Key customers
  • Exhibit 96: Tissue Regenix Group Plc - Vendor overview
  • Exhibit 97: Tissue Regenix Group Plc - Product segments
  • Exhibit 98: Tissue Regenix Group Plc - Organizational developments
  • Exhibit 99: Tissue Regenix Group Plc - Geographic focus
  • Exhibit 100: Tissue Regenix Group Plc - Segment focus
  • Exhibit 101: Tissue Regenix Group Plc - Key offerings
  • Exhibit 102: Tissue Regenix Group Plc - Key customers
  • Exhibit 103: Zimmer Biomet Holdings Inc. - Vendor overview
  • Exhibit 104: Zimmer Biomet Holdings Inc. - Product segments
  • Exhibit 105: Zimmer Biomet Holdings Inc. - Organizational developments
  • Exhibit 106: Zimmer Biomet Holdings Inc. - Geographic focus
  • Exhibit 107: Zimmer Biomet Holdings Inc. - Segment focus
  • Exhibit 108: Zimmer Biomet Holdings Inc. - Key offerings
  • Exhibit 109: Zimmer Biomet Holdings Inc. - Key customers
  • Exhibit 110: Validation techniques employed for market sizing
  • Exhibit 111: Definition of market positioning of vendors